Industry Trends

Loading...

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More



Sponsors Run to goBalto.com to Size Up Service Providers



Loading...

By Deb Borfitz

August 24, 2009 | A newly launched website—goBalto.com—is providing the drug development industry with unprecedented intelligence about their would-be partners around the world. Initial response to the site, in beta testing since April, suggests life science companies have been latently hungering for the resource. Membership has been growing at the rate of hundreds per week and now numbers around 5,000, says Jae Chung, goBalto’s founder and CEO. The company went from conception to incorporation in a week, with funding provided by angel investors.

Jae_Chung
Jae Chung
The pharmaceutical industry has been “one of the laggards” when it comes to having some sort of system for rating service providers, says Chung, who describes goBalto as a cross between consumer review sites Yelp and Expedia and the business networking site LinkedIn. In addition to reviewing past external partners, the goBalto user community can identify new ones—by name, region, and specialty—as well as ask questions, post requests for proposals, hold discussions, and collaborate.

The website’s name (I’m sure I don’t need to tell you) is derived from the Siberian Husky sled dog, Balto, who led his team on the final leg of the 1925 serum run to Nome to deliver diphtheria antitoxin.

Up until now, life science companies have located service providers either by word of mouth or time-consuming Internet searches producing a hodgepodge of results. “We can shave close to two months off the process of finding and evaluating vendors,” says Chung. For service providers, notably clinical research organizations, goBalto is also a convenient way to “stand out from the crowd.”

Although not its original intention, Chung says goBalto is also being used by service providers to rate pharmaceutical companies on the quality of their outsourcing teams. But the bulk of inquiries, up to 50 a day, are being generated by sponsors. About 30% of the overall user base resides in the U.S., another 30% in Europe, and the rest in Asia.

A combination of community policing and algorithms that flag excessive positive or negative reviews prevent ratings from being skewed. Multiple ratings help companies identify patterns. Anonymous ratings are forbidden.

The online directory of service providers includes close to 10,000 companies spanning more than 500 service categories, including all 2,000 or so CROs operating worldwide, says Chung. The site was initially seeded with close to 7,000 companies, most of which the goBalto staff found after an “excruciating” four months scouring the Internet. Another 3,000 companies added themselves. Proprietary lists and reviews of CROs by Pharma Services Network, ChinaBio, and Maya Clinicals are also part of the database.

The “engagement” piece of goBalto needs the most work, says Chung, adding that companies currently communicate primarily by email or teleconference. goBalto is experimenting with activity feeds, to help members keep up to date on opportunities, answers, resources, and company ratings. It also recently rolled out a discussion thread feature on its email system, allowing multiple contacts to keep a history of their discussion and send documents to each other. That could facilitate collaborative project management, he adds.

Self-described “net market makers” that attempted to blend community, content, and commerce a decade ago eventually went belly up. But goBalto, under Chung’s leadership, could be a winner if the revenue structure pans out. In 2002, Chung founded contract biopharmaceutical group Celltrion. The company is currently listed on the Korean KOSDAQ with a market capitalization of $1.6 billion.

Beta testing of goBalto is expected to conclude early next year. Meanwhile, additional service provider lists will be added to the online directory via partners in Europe and Latin America.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.




Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.